Elution of High Dose Amphotericin B Deoxycholate From Polymethylmethacrylate.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26162513.
- Also identified by DOI 10.1016/j.arth.2015.06.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fungal periprosthetic joint infections are rare, devastating complications of arthroplasty. There is conflicting evidence as to the efficacy of amphotericin B elution from cement spacers. The purpose of this study was to determine whether concentrations of amphotericin B released from bone cement over time would be efficacious in treating a periprosthetic infection. A continuous flow chamber was used to evaluate the in vitro release of amphotericin from cement beads containing 7.5% amphotericin. Following polymerization, 3.3% of the initially loaded amphotericin B was detected. The peak mean concentration eluted from the bone cement was 0.33 μg/mL at 8 hours. The AUC0-24 was 2.79 μg/mL/h; 0.20% of the amphotericin B was released. In conclusion, amphotericin B is released from bone cement at a clinically useful concentration.
Medical subject headings
- Amphotericin B
- Antifungal Agents
- Bone Cements
- Deoxycholic Acid
- Polymethyl Methacrylate